Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
Molecular Informatics · 2024
DOI: 10.1002/minf.202300279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Informatics, 2024. Verfasst von Anastasia D Fomina und 5 weiteren Autor:innen. Beteiligte Einrichtung: FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), 108819, Moscow, Russia. Hauptthemen laut MEDLINE: SARS-CoV-2, Molecular Docking Simulation, Protease Inhibitors, Coronavirus 3C Proteases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
During the first years of COVID‐19 pandemic, X‐ray structures of the coronavirus drug targets were acquired at an unprecedented rate, giving hundreds of PDB depositions in less than a year. The main protease (Mpro) of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) is the primary validated target of direct‐acting antivirals. The selection of the optimal ensemble of structures of Mpro for the docking‐driven virtual screening campaign was thus non‐trivial and required a systematic and automated approach. Here we report a semi‐automated active site RMSD based procedure of ensemble selection from the SARS‐CoV‐2 Mpro crystallographic data and virtual screening of its inhibitors. The procedure was compared with other approaches to ensemble selection and validated with the help of hand‐picked and peer‐reviewed activity‐annotated libraries. Prospective virtual screening of non‐covalent Mpro inhibitors resulted in a new chemotype of thienopyrimidinone derivatives with experimentally confirmed enzyme inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), 108819, Moscow, Russia.
- Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
- Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 119991, Moscow, Russia.
ORCID-Profile: Anastasia D Fomina
Zitieren
APA
Fomina, A. D., Uvarova, V. I., Kozlovskaya, L. I., Palyulin, V. A., Osolodkin, D. I., & Ishmukhametov, A. A. (2024). Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors. Molecular Informatics. https://doi.org/10.1002/minf.202300279
Vancouver
Fomina AD, Uvarova VI, Kozlovskaya LI, Palyulin VA, Osolodkin DI, Ishmukhametov AA. Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors. Molecular Informatics. 2024. doi:10.1002/minf.202300279
BibTeX
@article{Fomina2024,
author = {Fomina, Anastasia D and Uvarova, Victoria I and Kozlovskaya, Liubov I and Palyulin, Vladimir A and Osolodkin, Dmitry I and Ishmukhametov, Aydar A},
title = {Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors},
journal = {Molecular Informatics},
year = {2024},
doi = {10.1002/minf.202300279}
}
EUVIMED